Health

10 Tirzepatide Telehealth Services Worth Your Money in 2026

Written by John A · 4 min read >
10 Tirzepatide Telehealth Services Worth Your Money in 2026

The mistake most people make when comparing these services is fixating on the drug name and ignoring the pharmacy behind it. Tirzepatide is tirzepatide, right? Not exactly. Compounded versions vary by source, quality controls, and whether anyone has actually tested the finished vials. The platform you pick determines all of that, and the price swings are wild, sometimes $200 a month or more for what looks like the same weekly injection.

Here are ten options worth a real look, ranked roughly by overall value for cash-paying patients in 2026.

1. Mochi Health

Board-certified obesity-medicine clinicians, not general practitioners. Compounded tirzepatide starts at $199/mo, compounded semaglutide at $99. The monitoring is real: regular check-ins, metabolic labs, and clinicians who specialize in weight management rather than treating it as a side service. Best pick if clinical oversight matters more than rock-bottom price.

2. Henry Meds

Cash-pay, no insurance required, compounded GLP-1s starting around $179 for month one. Delivery typically lands within one to three business days. Lighter on ongoing monitoring than Mochi, which suits patients who just want the medication delivered quickly without a lot of back-and-forth. Pricing stays competitive into subsequent months.

3. FormBlends

FormBlends does something most telehealth GLP-1 brands skip entirely: it publishes per-product lab results with actual purity numbers, HPLC purity, mass spec identity confirmation, and endotoxin/sterility results, all traceable to named testing. That transparency costs something. Compounded semaglutide runs around $299 and tirzepatide around $349, higher than several competitors here. Ships to 47 states. The same clinician model also covers a wide peptide catalog covering recovery, longevity, and cognitive targets, so patients who want GLP-1s and other peptides from one provider without switching platforms will find it here. If published batch-level purity data or a broader peptide menu matters to you, FormBlends earns the extra spend. If you are purely optimizing for price, it does not beat entry-level options.

4. MEDVi

No contracts, compounded tirzepatide, first month around $179. Straightforward model with physician review and an uncomplicated cancellation policy. Good for patients who want to test the waters before committing long-term. Not the deepest monitoring program, but the pricing is honest upfront.

5. HealthRX

HealthRX keeps costs genuinely low: compounded tirzepatide from $149 a month, compounded semaglutide from $99. Free overnight shipping to all 50 states with no hidden fees at checkout. The physician review window is roughly 24 hours from submission. Medication is dispensed by Manifest Pharmacy in Greer, South Carolina, a 503A facility operating under USP-797 standards with lot-level tracking from compounding bench to your door. LegitScript certified (certificate 50087439). For a cash-pay patient who wants to know exactly which pharmacy mixed the medication and wants it there the next morning, this combination is hard to beat at this price point. The efficacy numbers it references, around 21% body weight reduction at 72 weeks for tirzepatide from SURMOUNT-1 trial data, apply to the active ingredient in clinical trials, not to any compounded product specifically. Worth knowing.

6. PlushCare

Membership at $19.99/mo, with same-day appointment availability and a genuine insurance billing path for branded GLP-1s like Wegovy and Zepbound. If you have decent insurance coverage or a Novo/Lilly savings card, PlushCare can get you to near-zero monthly cost on branded medication. Good infrastructure for the insurance-first patient.

7. Ro Body

First month around $39, then $74 to $149/mo for the platform, with meds billed separately. Ro has a dedicated prior-authorization team to chase insurance approvals, which saves real hours of phone time. Takes insurance for branded GLP-1s. A solid choice for anyone willing to work the insurance process.

8. Hims & Hers

Following the Novo Nordisk settlement in March 2026, the company shifted its GLP-1 offerings to branded medications. Injectable Wegovy runs about $299/mo through them, oral Wegovy around $249, and Zepbound around $399 before any savings cards. With insurance plus manufacturer discounts that can drop to $0 to $25. Best positioned for patients with insurance who want a recognizable brand experience.

9. Found

$99/mo for the platform plus medication costs on top. Includes behavioral coaching and a structured approach rather than medication alone. Not the cheapest combined cost, but the coaching component is built in rather than an add-on.

10. Sesame

Annual membership from around $59/mo with medications billed separately. Sesame sits closer to a marketplace than a dedicated weight-loss program, connecting patients to independent clinicians. Pricing flexibility is real, though the experience is less hand-held than dedicated GLP-1 platforms.

*A note before you decide: compounded GLP-1 medications are not FDA-approved finished products, and the FDA issued warning letters to more than 30 telehealth and compounding operations in early 2026. Prices shift. Verify current pricing and your provider’s current pharmacy status directly before purchasing anything.*

Common Questions

Which of these platforms actually tells you which pharmacy compounds your tirzepatide?

HealthRX names its pharmacy outright: Manifest Pharmacy in Greer, South Carolina, a 503A facility with lot-level tracking. FormBlends publishes batch-level lab results tied to named testing. Most other platforms here do not publicly identify their compounding source, which is worth pressing them on before you order.

Does paying more per month actually get you better medical oversight, or just a fancier app?

It depends on the platform. Mochi Health uses board-certified obesity-medicine specialists and includes metabolic labs, which is meaningfully different from a one-time async physician review. Found layers in behavioral coaching. Henry Meds and MEDVi are leaner on follow-up. Higher price does not automatically equal better monitoring, so read what the check-in process actually looks like.

If my insurance might cover Zepbound or Wegovy, which of these services handles that best?

Ro Body has a dedicated prior-authorization team that does the insurance legwork for you. PlushCare also has a real insurance billing path and can get patients to near-zero monthly cost when coverage and manufacturer savings cards align. Both are better suited to the insurance route than cash-pay-first platforms like Henry Meds or HealthRX.

After the FDA warning letters in early 2026, how do I know a platform’s compounding pharmacy is still operating legally?

Check two things: whether the pharmacy holds a current 503A or 503B designation from the FDA, and whether the telehealth platform carries a LegitScript certification. HealthRX publishes its LegitScript certificate number (50087439). For any platform not listed here, search the FDA’s compounding pharmacy database and LegitScript’s public directory directly before purchasing.

Is the 21% weight-loss figure that some of these platforms advertise actually what patients should expect from compounded tirzepatide?

No. That figure comes from the SURMOUNT-1 clinical trial, which used pharmaceutical-grade tirzepatide in a controlled setting with weekly dose escalation and close monitoring. Compounded versions have not been tested in equivalent trials. Real-world results vary based on adherence, dose, diet, and individual response. Treat that number as context for the active ingredient, not a promise about any specific product.

Sources

  • FDA: Warning Letters to Compounding Facilities and Telehealth Platforms (2026)
  • SURMOUNT-1 trial: Jastreboff et al., *New England Journal of Medicine*, 2022 (tirzepatide weight-loss outcomes)
  • STEP 1 trial: Wilding et al., *New England Journal of Medicine*, 2021 (semaglutide weight-loss outcomes)
  • Novo Nordisk settlement announcement (March 9, 2026), publicly reported across health news outlets
  • LegitScript public certification directory
  • Individual brand pricing pages (verified independently, subject to change)

Leave a Reply

Your email address will not be published. Required fields are marked *